Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$5.25
+0.0150 (+0.287%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.61 $6.10 Friday, 10th May 2024 AFMD stock ended at $5.25. This is 0.287% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.28% from a day low at $5.11 to a day high of $5.33.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Dec 16, 2022 $11.20 $11.40 $10.50 $11.20 360 624
Dec 15, 2022 $11.50 $12.00 $11.00 $11.10 187 170
Dec 14, 2022 $12.10 $12.50 $11.60 $11.80 327 652
Dec 13, 2022 $13.90 $14.05 $11.80 $12.00 432 963
Dec 12, 2022 $15.10 $15.20 $10.30 $13.60 1 475 355
Dec 09, 2022 $20.30 $20.80 $20.30 $20.40 90 784
Dec 08, 2022 $19.10 $20.70 $19.05 $20.50 108 859
Dec 07, 2022 $19.90 $20.00 $18.40 $19.10 307 353
Dec 06, 2022 $21.00 $21.30 $19.70 $19.90 207 371
Dec 05, 2022 $20.80 $21.50 $20.53 $21.20 207 749
Dec 02, 2022 $20.40 $20.95 $19.80 $20.90 219 688
Dec 01, 2022 $21.30 $21.85 $20.30 $20.40 72 537
Nov 30, 2022 $20.10 $21.50 $19.90 $21.40 240 277
Nov 29, 2022 $20.10 $20.70 $19.50 $19.90 106 912
Nov 28, 2022 $21.10 $21.50 $20.12 $20.40 189 452
Nov 25, 2022 $20.90 $21.50 $20.80 $20.90 53 117
Nov 23, 2022 $21.20 $22.31 $21.00 $21.10 129 806
Nov 22, 2022 $21.60 $21.90 $20.60 $21.40 116 094
Nov 21, 2022 $20.10 $21.60 $20.00 $21.05 124 202
Nov 18, 2022 $21.40 $21.50 $20.13 $20.25 132 770
Nov 17, 2022 $23.70 $23.75 $20.80 $21.15 202 432
Nov 16, 2022 $22.90 $25.10 $22.45 $24.50 306 590
Nov 15, 2022 $23.00 $23.30 $21.00 $23.29 215 751
Nov 14, 2022 $21.80 $22.20 $20.21 $20.55 131 577
Nov 11, 2022 $22.60 $23.20 $21.50 $21.65 152 140
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT